Their AUCs were similar to common CRC blood biomarkers CEA, CA125, and CA19-9 but still smaller than the AUC of m6A. Collectively, IGF2BP2 in peripheral blood immune cells was a potentially valuable diagnostic biomarker for CRC associated with m6A modification. This evidence concerns the gene CEACAM5 and colorectal carcinoma.